A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute

Journal of Artificial Organs

Volumn 13, Issue 2, 2010, Pages 101-105

  Ohara, Naoki ^a   Mihara, Shoji ^a   Nihara, Hiroyuki ^a   Akimoto, Narihiro ^a   Naoki Madokoro, ^a   Kawai, Mikio ^a   Noda, Hideki ^a   Hide, Michihiro ^a   Matsumoto, Yasuhiro ^b   Kuroyanagi, Yoshimitsu ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Allogeneic cultured dermal substitute; Amputation; Deep burn; Fibroblasts; Periosteal necrosis

Indexed keywords

WOUND HEALING PROMOTING AGENT;

AGED; ALLOTRANSPLANTATION; ANEMIA; ARTICLE; BONE NECROSIS; BURN; BURN INFECTION; BURN SHOCK; CASE REPORT; DEBRIDEMENT; FEMALE; FEMUR NECK FRACTURE; HUMAN; HYPOTENSION; OSTEOSYNTHESIS; PERIOSTEUM; PRIORITY JOURNAL; SKIN CULTURE; SKIN TRANSPLANTATION; THROMBOCYTOPENIA; WOUND HEALING; WOUND IRRIGATION; ARTIFICIAL SKIN; BURNS; NECROSIS; PATHOLOGY; PROCEDURES; SKIN; SKIN SURGERY; VERY ELDERLY;

AGED, 80 AND OVER; BURNS; FEMALE; HUMANS; NECROSIS; PERIOSTEUM; SKIN; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; WOUND HEALING; DERMATOLOGIC SURGICAL PROCEDURES;

EID: 77956455697     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0499-7     Document Type: Article

References (28)

1. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation. J Biomater Sci Polymer Edn. 2003;14:625-41. (Pubitemid 36926689)
2. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute; evaluation in an animal test. J Artif Organs. 2003;6:64-70.
3. Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs. 2003;6:138-44. (Pubitemid 36829956)
4. Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs. 2004;28:444-50.
5. Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, et al. Digital gangrene associated with idiopathic hypereosinophilia; treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol. 2004;14:168-71
6. Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, et al. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol. 2004;14:172-6.
7. Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, et al. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2004;50:803-4.
8. Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, et al. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects priorto autologous skin grafting: three case reports. J Dermatol.2005;32:715-20.
9. Kishioka A, Yamamoto Y, Furukawa F, Kawasaki S, Shinozaki M, Hashimoto A, et al. Report of a case of burns to both legs successfully treated with cultured dermal substitute. Jpn J Burn Injuries. 2006;32:48-52.
10. Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Mizuno Y, Haruna K, et al. Intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute. Scand J Plast ReconstrSurg Hand Surg. 2007;41:326-8.
11. Yonezawa M, Tanizaki H, Inoguchi N, Ishida M, Katoh M, achibana T, et al. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. Int J Dermatol. 2007;46:36-42.
12. Nishimoto J, Amoh Y, Tanabe K, Niiyama N, Katsuoka K, uroyanagi Y. Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with llogeneic cultured dermal substitute. Eur J Dermatol.2007;17:350-1.
13. Yamada N, Uchinuma E, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for intractable skin ulcers of the lower leg. J Artif Organs. 2008;11:100-3.
14. Yamada N, Uchinuma E, Matsumoto Y, Kuroyanagi Y. Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute. J Artif Organs.2008;11:221-1.
15. Toyozawa S, Yamamoto Y, Nishide T, Kishioka A, Kanazawa N, Matsumoto Y, et al. Case report; a case of pyoderma gangreno-sum with intractable leg ulcers treated by allogeneic cultured dermal substitutes. Dermatol Online J. 2008;14:17.
16. Kuroyanagi Y, Kubo K, Matsui H, Kim HJ, Numari S, MabuchiY, et al. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs. 2004;28:13-21.
17. Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro J Artif Organs. 2003;6:267-72.
18. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts; cryopreservation. Artif Organs. 2004;28:182-8.
19. Kubo K, Kuroyanagi Y. The possibility of long-term cryopreservation of cultured dermal substitute. Artif Organs. 2005;29:800-5. (Pubitemid 43934119)
20. Kubo K, Kuroyanagi Y. A study of cytokines released from fibro blasts in cultured dermal substitute. Artifi Organs. 2005;29:845-9.
21. Hashimoto A, Kuroyanagi Y. Standardization for mass production of allogeneic cultured dermal substitute by measuring theamount of VEGF, bFGF, HGF, TGF-/J, and IL-8. J Artif Organs.2008;11:225-31.
22. Clarke RA. Overview and general considerations of wound repair. In: Clarke RAF, Henson PM, editors. The molecular and cellular biology of wound repair. New York: Plenum; 1988.p. 18-22.
23. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA. 1978;75:871-5.
24. Cohn RH, Cassiman JJ, Bernfield MR. Relationship of transformation, cell density and growth control to cellular distribution of newly synthesized glycosaminoglycan. J Cell Biol. 1976; 71:280-94.
25. Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials. 1993;14:1154-60.
26. Heymans O, Verhelle N, Peters S, Neelissen X, Oelbrandt B. Useof the medial adipofascial flap of the leg for coverage of full-thickness burns exposing the tibial crest. Burns. 2002;28:674-8.
27. Gospodarowicz D. Localisation of a fibroblast growth factor andits effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974;249:123-7.
28. Yokouchi T, Daian T. Combined therapy of artificial dermis and bFGF for exposed leg bone. Med Consult New Remedies.2005;42:1117-8.